+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endocrine And Metabolic Disorders Drugs Market Research Reports

From
From
From
From
From
From
From
From
Gouty Arthritis (Gout) - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Gouty Arthritis (Gout) - Global Clinical Trials Review, 2025

  • Clinical Trials
  • November 2025
  • 711 Pages
  • Global
From
Hyperphosphatemia Treatment Market - Forecast from 2026 to 2031 - Product Thumbnail Image

Hyperphosphatemia Treatment Market - Forecast from 2026 to 2031

  • Report
  • January 2026
  • 140 Pages
  • Global
From
Gout Therapeutics Market - Forecast from 2026 to 2031 - Product Thumbnail Image

Gout Therapeutics Market - Forecast from 2026 to 2031

  • Report
  • January 2026
  • 151 Pages
  • Global
From
Insulin Storage Devices Market - Forecast from 2026 to 2031 - Product Thumbnail Image

Insulin Storage Devices Market - Forecast from 2026 to 2031

  • Report
  • January 2026
  • 128 Pages
  • Global
From
Insulin Pens Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Insulin Pens Market - Forecasts from 2025 to 2030

  • Report
  • November 2025
  • 145 Pages
  • Global
From
From
Loading Indicator

The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders. Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists. Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more